tiprankstipranks
Aldeyra Therapeutics (ALDX)
NASDAQ:ALDX
US Market
Want to see ALDX full AI Analyst Report?

Aldeyra Therapeutics (ALDX) Stock Forecast & Price Target

1,734 Followers
See the Price Targets and Ratings of:

ALDX Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Aldeyra
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ALDX Stock 12 Month Forecast

There Are No Analyst Ratings for ALDX In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

ALDX Financial Forecast

ALDX Earnings Forecast

The previous quarter’s earnings for ALDX were -$0.09.
The previous quarter’s earnings for ALDX were -$0.09.
No data currently available

ALDX Sales Forecast

The previous quarter’s earnings for ALDX were $0.00.
The previous quarter’s earnings for ALDX were $0.00.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on ALDX
H.C. Wainwright
H.C. Wainwright
$2
Hold
31.58%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (NASDAQ: ELVN), Molina Healthcare (NYSE: MOH) and Aldeyra Therapeutics (NASDAQ: ALDX)
BTIG
$9
Buy
492.11%
Upside
Reiterated
03/17/26
Analysts Are Bullish on These Healthcare Stocks: Healthequity (HQY), Kestra Medical Technologies Ltd. (KMTS)
Jefferies Analyst forecast on ALDX
Jefferies
Jefferies
$7
Buy
360.53%
Upside
Reiterated
10/08/25
Promising Developments and Strategic Partnerships Drive Buy Rating for Aldeyra Therapeutics
Leerink Partners Analyst forecast on ALDX
Leerink Partners
Leerink Partners
$10
Buy
557.89%
Upside
Reiterated
08/12/25
Aldeyra Therapeutics: Positive NDA Resubmission and Strategic Advancements Support Buy Rating
JonesTrading Analyst forecast on ALDX
JonesTrading
JonesTrading
$6$9
Buy
492.11%
Upside
Reiterated
08/08/25
Aldeyra Therapeutics (ALDX) Receives a Buy from JonesTrading
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on ALDX
H.C. Wainwright
H.C. Wainwright
$2
Hold
31.58%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Enliven Therapeutics (NASDAQ: ELVN), Molina Healthcare (NYSE: MOH) and Aldeyra Therapeutics (NASDAQ: ALDX)
BTIG
$9
Buy
492.11%
Upside
Reiterated
03/17/26
Analysts Are Bullish on These Healthcare Stocks: Healthequity (HQY), Kestra Medical Technologies Ltd. (KMTS)
Jefferies Analyst forecast on ALDX
Jefferies
Jefferies
$7
Buy
360.53%
Upside
Reiterated
10/08/25
Promising Developments and Strategic Partnerships Drive Buy Rating for Aldeyra Therapeutics
Leerink Partners Analyst forecast on ALDX
Leerink Partners
Leerink Partners
$10
Buy
557.89%
Upside
Reiterated
08/12/25
Aldeyra Therapeutics: Positive NDA Resubmission and Strategic Advancements Support Buy Rating
JonesTrading Analyst forecast on ALDX
JonesTrading
JonesTrading
$6$9
Buy
492.11%
Upside
Reiterated
08/08/25
Aldeyra Therapeutics (ALDX) Receives a Buy from JonesTrading
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BTSGBrightSpring Health Services, Inc.
ACRVAcrivon Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
TNYATenaya Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Aldeyra Therapeutics

3 Months
Marc GoodmanLeerink Partners
Success Rate
15/25 ratings generated profit
60%
Average Return
+21.34%
Copying Marc Goodman's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +21.34% per trade.
1 Year
Marc GoodmanLeerink Partners
Success Rate
12/25 ratings generated profit
48%
Average Return
+21.52%
Copying Marc Goodman's trades and holding each position for 1 Year would result in 48.00% of your transactions generating a profit, with an average return of +21.52% per trade.
2 Years
Marc GoodmanLeerink Partners
Success Rate
8/25 ratings generated profit
32%
Average Return
-16.99%
Copying Marc Goodman's trades and holding each position for 2 Years would result in 32.00% of your transactions generating a profit, with an average return of -16.99% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALDX Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
2
2
0
0
0
Buy
0
0
0
0
0
Hold
1
2
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
4
1
1
0
In the current month, ALDX has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ALDX average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

ALDX Stock Forecast FAQ

What is ALDX’s average 12-month price target, according to analysts?
Currently, no data Available
What is ALDX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for ALDX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is ALDX a Buy, Sell or Hold?
      Currently, no data Available
      What is Aldeyra Therapeutics’s price target?
      Currently, no data Available
      What do analysts say about Aldeyra Therapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of ALDX?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.